Yutaka Wakasa

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy

Sunao Kojima, Kunihiko Matsui, Shinya Hiramitsu et al. · European Heart Journal · 2019 · 231 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +10

Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia

Sunao Kojima, Kunihiko Matsui, Hisao Ogawa et al. · Journal of Cardiology · 2016 · 43 citations

Medicine, Nephrology, Pharmacotherapy +5

Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease

Masaaki Konishi, Sunao Kojima, Kazuaki Uchiyama et al. · International Journal of Cardiology · 2021 · 38 citations

Medicine, Nephrology, Pharmacotherapy +6

Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: <i>post hoc</i> analysis of a randomized controlled trial

Sunao Kojima, Kazuaki Uchiyama, Naoto Yokota et al. · Lara D. Veeken · 2021 · 17 citations

Veterinary Medicine, Geriatric Medicine, Pharmacotherapy +12

Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease

Ryo Naito, Katsumi Miyauchi, Satoshi Yasuda et al. · JAMA Cardiology · 2022 · 14 citations · Full text

Medicine, Cardiology, Pharmacology +17